Download PDFPDF
Risk of lymphoproliferative cancer among patients with severe rheumatoid arthritis, 1996–2002
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g.
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests


  • Responses are moderated before posting and publication is at the absolute discretion of BMJ, however they are not peer-reviewed
  • Once published, you will not have the right to remove or edit your response. Removal or editing of responses is at BMJ's absolute discretion
  • If patients could recognise themselves, or anyone else could recognise a patient from your description, please obtain the patient's written consent to publication and send them to the editorial office before submitting your response [Patient consent forms]
  • By submitting this response you are agreeing to our full [Response terms and requirements]

Vertical Tabs

Other responses

Jump to comment:

  • Published on:
    irreversible hodgkin's lymphoma in 2 patients treated with methotrexate
    • vladimir gotlieb, the Brooklyn hospital center
    • Other Contributors:
      • Samer Khaled, Dmitri Baranov, Arun Patel

    Dear Editor

    As it was mentioned in multiple manuscripts related to the topic several different possibilities could explain why the patients develop enlarged lymph nodes. Among those are indolent lymphomas, lymphatic hyperplasia and aggressive lymphomas, including both Hodgkin’s lymphoma and large B-cell lymphoma, which are usually associated with Epstein-Barr infection, The other possibilities include Castelman’s D...

    Show More
    Conflict of Interest:
    None declared.